Industry Relations Council
Participation in HOPA's Industry Relations Council is open to all organizations that support our mission and the work of hematology/oncology pharmacists. When you become an IRC participant, you are in very good company - the IRC consists of both new and established brands in pharmaceuticals, medical devices, and industry publications. We thank these companies for your recent support (view IRC participant roster.)
Download our IRC Brochure or contact Laurie Rappa, Senior Development Director, at 877.467.2791 or lrappa@hoparx.org.
The Hematology/Oncology Pharmacy Association (HOPA) is committed to optimizing cancer care for all individuals. The recent U.S. Supreme Court decision, which overturned Roe v. Wade, imposes a significant barrier to the oncology community’s ability to ens
Heidi D. Finnes, PharmD, BCOP, FHOPA became President of the Hematology/ Oncology Pharmacy Association (HOPA) on April 1, 2022 at the association’s annual conference in Boston, Massachusetts.
